Dendritic cell-glioma fusion activates T lymphocytes by elevating cytotoxic efficiency as an antitumor vaccine

BACKGROUND: Hybrid cells produced by fusions of tumor and dendritic cells (DC) have demonstrated remarkable efficacy for priming the anti-tumor immune response. In the current study, we examined the antitumor activity of cytotoxic T lymphocytes (CTLs) primed in response to a tumor vaccine comprising...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cent Eur J Immunol
Hoofdauteurs: Tian, Fuming, Dou, Changwu, Qi, Songtao, Chen, Bo, Zhao, Liqun, Wang, Xiaojuan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Polish Society of Experimental and Clinical Immunology 2014
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4439993/
https://ncbi.nlm.nih.gov/pubmed/26155134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2014.45935
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items